Could COVID Tech Help Treat Rare Diseases? 🤯

One unexpected benefit of the pandemic? The technology used to deliver COVID vaccines became much cheaper and easier to manufacture at scale, opening new possibilities for genetic medicine. Dr. Trevor Martin, CEO of Mammoth Biosciences, explains how advances in lipid nanoparticles could help bring gene-editing treatments to millions of patients while making therapies for rare genetic diseases more feasible. Watch the full episode! #CRISPR #GeneEditing #GeneticMedicine #Biotech #MammothBiosciences #TheNeuron